Knoll Capital Management, LP is an institution, managing $186.6M across 38 long positions as of Q3 2025 with 55% Healthcare concentration, 64% concentrated in top 10 holdings, and 15% allocation to ALDX.
Largest long holdings in Knoll Capital Management, LP's portfolio (64.1% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Biotechnology Healthcare | $28.6M | 15.32% | — | 9.12% 5.5M shares | |
Biotechnology Healthcare | $13.4M | 7.20% | — | 0.85% 895.3K shares | |
Unknown Unknown | $11.4M | 6.10% | — | — 32.0K shares | |
Biotechnology Healthcare | $11.3M | 6.05% | — | 12.88% 5.9M shares | |
Biotechnology Healthcare | $10.3M | 5.51% | — | 1.55% 1.3M shares | |
Gold Basic Materials | $10.2M | 5.46% | -$745.5K Sold | 0.03% 410.0K shares | |
Drug Manufacturers - Specialty & Generic Healthcare | $9.2M | 4.91% | — | 0.62% 600.0K shares | |
Gold Basic Materials | $8.9M | 4.76% | -$463.5K Sold | 0.01% 52.8K shares | |
Gold Basic Materials | $8.8M | 4.70% | — | 0.24% 700.0K shares | |
Gold Basic Materials | $7.7M | 4.10% | — | 0.31% 317.0K shares |
Portfolio activity, position movements, and quarter-over-quarter changes in Knoll Capital Management, LP's latest filing
| Position | Shares Δ |
|---|---|
New | |
New |
| Position | Shares Δ |
|---|---|
Sold | |
Sold | |
Sold | |
-59.49% | |
-6.82% |
Portfolio insights and performance metrics for Knoll Capital Management, LP
We use cookies for analytics. See our Privacy and Cookie Policy.